Viewing Study NCT05138133


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
Study NCT ID: NCT05138133
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2021-11-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module